CBYL AS OF 03/31/2015

Company

KalVista Pharmaceuticals, Inc.

Filed

May 11, 2015

Accession Number

0000080255-15-000587

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →